RXDX - Prometheus Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Prometheus Biosciences's activity chart (see below) currently has 84 price targets and 76 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.22% with an average time for these price targets to be met of 263.18 days.

Most recent stock forecast was given by from UBS on 10-May-2023. First documented stock forecast 22-Jun-2015.

Best performing analysts who are covering RXDX - Prometheus Biosciences:

Yatin Suneja Julian Harrison Yasmeen Rahimi Joshua Schimmer Chris Shibutani

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Feb-2023

$160

$-39.92 (-19.97%)

$160

Hold Since 10-May-2023

$200

$0.08 (0.04%)

$140

Buy Since 26-Apr-2021

$200

$0.08 (0.04%)

$139

Buy Since 06-Apr-2021

$200

$0.08 (0.04%)

$225

Show more analysts

Please expand the browser size to see the chart

What is RXDX (Prometheus Biosciences) average time for price targets to be met?

On average it took 263.18 days on average for the stock forecasts to be realized with a an average price target met ratio 86.22

Which analyst has the current highest performing score on RXDX (Prometheus Biosciences) with a proven track record?

Which analyst has the most public recommendations on RXDX (Prometheus Biosciences)?

has 0 price targets and 0 ratings on RXDX

Which analyst is the currently most bullish on RXDX (Prometheus Biosciences)?

Chris Carey with highest potential upside - $25.53

Which analyst is the currently most reserved on RXDX (Prometheus Biosciences)?

Gena Wang with lowest potential downside - -$179.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?